Newswise — Wilmington, Delaware, June 12, 2018 — The subject of TV news programs and magazine headlines, CRISPR gene editing technology is spearheading a biomedical revolution. Scientists are working to alter mosquito DNA to prevent malaria and modify pig organs for human transplant. The Gene Editing Institute of Christiana Care Health System is researching the use of CRISPR in lung cancer treatments.
But who owns CRISPR and its related technologies? Will insurance pay for gene editing procedures
MEDIA CONTACT
Register for reporter access to contact detailsArticle Multimedia
Credit: Christiana Care Health System
Caption: Eric Kmiec, Ph.D., interviews Edmund Pezalla, M.D., MPH, Ph.D., founder and CEO of Enlightenment Bioconsult, about insurance issues related to patient treatments that could use CRISPR gene editing
Credit: Christiana Care Health System
Caption: Eric Kmiec, Ph.D., interviews Debra J. H. Mathews, Ph.D., MA, assistant director for science programs for the Johns Hopkins Berman Institute of Bioethics and associate professor in the department of pediatrics at John Hopkins University School of Medicine, about ethical issues related to CRISPR gene editing technology
Credit: Christiana Care Health System
Caption: Video of Eric Kmiec, Ph.D., interviewing Bob Oakes, Esq., patent attorney from Fish & Richardson, about patent issues related to CRISPR gene editing technology
RSS